| Type | Filer | #Shares | Filed | For date | #Previous | %Chg | Prev. Date |
|---|---|---|---|---|---|---|---|
|
SC 13G
|
Decheng Capital Global Life Sciences Fund IV, L.P | 3.09 mm | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | - |
|
13F-HR
|
Samsara BioCapital | 2.22 mm | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
|
13F-HR
|
Jane Street | 45.55 k | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
|
13F-HR
|
Nantahala Capital Management | 600.00 k | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
|
13F-HR
|
Soros Fund Management | 46.35 k | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
|
13F-HR
|
TCG Crossover Management | 2.80 mm | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
|
SC 13G
|
TCG Crossover GP I | 2.80 mm | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | - |
|
13F-HR
|
VR Adviser | 2.30 mm | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
|
13F-HR
|
Enavate Sciences GP | 2.46 mm | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | - |
|
13F-HR
|
Morgan Stanley | 796.00 | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
This data is updated daily from 13F, 13D and 13G SEC filings.
Faded values represent incomplete data for the quarter, where values have been used from the previous quarter for institutions that haven't filed updated data yet.
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.
